NeurAxis, Inc. (NRXS) financial statements and ratios from SEC XBRL: revenue $3.57M (TTM), net margin -218.5%, revenue growth 32.9% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $3.57M |
| Net Margin | -218.5% |
| Return on Equity | -114.0% |
| Debt / Equity | 0.01 |
| Current Ratio | 3.04 |
| Revenue Growth (YoY) | 32.9% |
| EPS Growth (YoY) | -22.1% |
| FCF Growth (YoY) | 5.5% |
| Price / Book | 11.69 |
| Price / Sales | 13.22 |
| FCF Yield | -8.6% |
| Altman Z-Score | -3.04 (distress) |
| Piotroski F-Score | 4/9 |
| Sector P/E (Healthcare) | 21.6 |
NRXS overview · NRXS earnings · NRXS KPIs · NRXS investor relations · NRXS ownership · NRXS peers · NRXS filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.